Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.
Resource Type
Authors
Tamborero D; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden. david.tamborero@ki.se.; Dienstmann R; Medical Oncology, Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Rachid MH; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.; Boekel J; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.; Lopez-Fernandez A; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Jonsson M; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.; Razzak A; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.; Braña I; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; De Petris L; Department of Oncology and Pathology, Karolinska Institutet, Theme Cancer, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden.; Yachnin J; Department of Oncology and Pathology, Karolinska Institutet, Theme Cancer, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden.; Baird RD; Cancer Research UK Cambridge Centre, Cambridge, UK.; Loriot Y; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Massard C; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Martin-Romano P; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Opdam F; The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Schlenk RF; NCT Trial Center, German Cancer Research Center, Heidelberg University Hospital, Heidelberg, Germany.; Vernieri C; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; IFOM, FIRC Institute of Molecular Oncology, Milan, Italy.; Masucci M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Villalobos X; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Chavarria E; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Balmaña J; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Apolone G; Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Caldas C; Cancer Research UK Cambridge Centre, Cambridge, UK.; Bergh J; Department of Oncology and Pathology, Karolinska Institutet, Theme Cancer, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden.; Ernberg I; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Fröhling S; National Center for Tumor Diseases Heidelberg, German Cancer Research Center, Heidelberg, Germany.; Garralda E; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Karlsson C; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.; Tabernero J; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Voest E; The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Rodon J; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lehtiö J; Clinical Proteomics Unit, Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Karolinska University Hospital, Stockholm, Sweden. janne.lehtio@ki.se.
Source
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: PubMed not MEDLINE; MEDLINE